X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
22
PharmaCompass offers a list of Trilaciclib Dihydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Trilaciclib Dihydrochloride manufacturer or Trilaciclib Dihydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Trilaciclib Dihydrochloride manufacturer or Trilaciclib Dihydrochloride supplier.
PharmaCompass also assists you with knowing the Trilaciclib Dihydrochloride API Price utilized in the formulation of products. Trilaciclib Dihydrochloride API Price is not always fixed or binding as the Trilaciclib Dihydrochloride Price is obtained through a variety of data sources. The Trilaciclib Dihydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Trilaciclib Dihydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trilaciclib Dihydrochloride, including repackagers and relabelers. The FDA regulates Trilaciclib Dihydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trilaciclib Dihydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Trilaciclib Dihydrochloride supplier is an individual or a company that provides Trilaciclib Dihydrochloride active pharmaceutical ingredient (API) or Trilaciclib Dihydrochloride finished formulations upon request. The Trilaciclib Dihydrochloride suppliers may include Trilaciclib Dihydrochloride API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Trilaciclib Dihydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Trilaciclib Dihydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Trilaciclib Dihydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Trilaciclib Dihydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Trilaciclib Dihydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Trilaciclib Dihydrochloride suppliers with NDC on PharmaCompass.
Trilaciclib Dihydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trilaciclib Dihydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trilaciclib Dihydrochloride GMP manufacturer or Trilaciclib Dihydrochloride GMP API supplier for your needs.
A Trilaciclib Dihydrochloride CoA (Certificate of Analysis) is a formal document that attests to Trilaciclib Dihydrochloride's compliance with Trilaciclib Dihydrochloride specifications and serves as a tool for batch-level quality control.
Trilaciclib Dihydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Trilaciclib Dihydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trilaciclib Dihydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Trilaciclib Dihydrochloride EP), Trilaciclib Dihydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trilaciclib Dihydrochloride USP).
Market Place
